Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients.

Zachary Klaassen, Roberto Muller, Qiang Li, Alexander J Tatem, Sherita A King, Stephen J Freedland, Rabii Madi, Martha K Terris, Kelvin A Moses

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in International scholarly research notices, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zachary KlaassenDepartment of Surgery, Section of Urology, Charlie Norwood Veteran's Administration Medical Center, Augusta, GA 30904, USA; Department of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA.ORCID 0000-0002-4997-6018

Roberto MullerSection of Surgery, Division of Urology, Durham Veteran's Administration Medical Center, Durham, NC 27705, USA.

Qiang LiDepartment of Surgery, Section of Urology, Charlie Norwood Veteran's Administration Medical Center, Augusta, GA 30904, USA; Department of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA.

Alexander J TatemDepartment of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA.

Sherita A KingDepartment of Surgery, Section of Urology, Charlie Norwood Veteran's Administration Medical Center, Augusta, GA 30904, USA; Department of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA.

Stephen J FreedlandSection of Surgery, Division of Urology, Durham Veteran's Administration Medical Center, Durham, NC 27705, USA; Departments of Surgery and Pathology, Division of Urology, Duke University School of Medicine, Durham, NC 27710, USA.

Rabii MadiDepartment of Surgery, Section of Urology, Charlie Norwood Veteran's Administration Medical Center, Augusta, GA 30904, USA; Department of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA.

Martha K TerrisDepartment of Surgery, Section of Urology, Charlie Norwood Veteran's Administration Medical Center, Augusta, GA 30904, USA; Department of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA.

Kelvin A MosesDepartment of Surgery, Section of Urology, Charlie Norwood Veteran's Administration Medical Center, Augusta, GA 30904, USA; Department of Surgery, Section of Urology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA; Department of Urologic Surgery, Vanderbilt University, A-1302 Medical Center North, Nashville, TN 37232, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective. To assess the impact of comorbidity, race, and marital status on overall survival (OS) among men presenting for prostate biopsy with PSA >20 ng/mL. Methods. Data were reviewed from 2000 to 2012 and 78 patients were included in the cohort. We analyzed predictors of OS using a Cox proportional hazards model and the association between Charlson Comorbidity Index (CCI) score and PCa diagnosis or high-grade cancer using logistic regression and multinomial regression models, respectively. Results. The median age of patients was 62.5 (IQR 57-73) years. Median CCI was 3 (IQR 2-4), 69% of patients were African American men, 56% of patients were married, and 85% of patients had a positive biopsy. CCI (HR 1.52, 95% CI 1.19, 1.94), PSA (HR 1.62, 95% CI 1.09, 2.42), and Gleason sum (HR 2.04, 95% CI 1.17, 3.56) were associated with OS. CCI was associated with Gleason sum 7 (OR 4.06, 95% CI 1.04, 15.89) and Gleason sum 8-10 (OR 4.52, 95% CI 1.16, 17.54) PCa. Conclusions. CCI is an independent predictor of high-grade disease and worse OS among men with PCa. Race and marital status were not significantly associated with survival in this cohort. Patient comorbidity is an important component of determining the optimal approach to management of prostate cancer.

Identifiers

PMID27355056

DOI10.1155/2014/362814

PMCPMC4897532

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.